HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors.
Taimur Khalid, Hazem Aboaid, Daniel Thomas Jones, Jason Ta, Ramaditya Srinivasmurthy, Kenny Do, Kevin Nguyen, Karina Fama, Rishi Kumar Nanda, Sarah Aamer, Jo-Lawrence Bigcas, Kyaw Zin Thein
Author Information
- Taimur Khalid: 1Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV.
- Hazem Aboaid: 2Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV.
- Daniel Thomas Jones: 3Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV.
- Jason Ta: 3Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV.
- Ramaditya Srinivasmurthy: 3Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV.
- Kenny Do: 1Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV.
- Kevin Nguyen: 3Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV.
- Karina Fama: 3Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV.
- Rishi Kumar Nanda: 3Touro University Nevada College of Osteopathic Medicine, Las Vegas, NV.
- Sarah Aamer: 2Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV.
- Jo-Lawrence Bigcas: 4Department of Otolaryngology - Head & Neck Surgery, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV.
- Kyaw Zin Thein: 5Division of Hematology and Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV.
No abstract text available.
